Literature DB >> 26252134

Benchmarking the scientific output of the Innovative Medicines Initiative.

Magda Gunn1, Mark Lim2, Didi Cross3, Michel Goldman4.   

Abstract

Mesh:

Year:  2015        PMID: 26252134     DOI: 10.1038/nbt.3305

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  I-SPY 2 may change how clinical trials are conducted: researchers aim to accelerate approvals of cancer drugs.

Authors:  Carrie Printz
Journal:  Cancer       Date:  2013-06-01       Impact factor: 6.860

2.  The Innovative Medicines Initiative: an engine for regulatory science.

Authors:  Michel Goldman; Nathalie Seigneuret; Hans-Georg Eichler
Journal:  Nat Rev Drug Discov       Date:  2014-12-12       Impact factor: 84.694

3.  Consortium sandbox: building and sharing resources.

Authors:  Mark D Lim
Journal:  Sci Transl Med       Date:  2014-06-25       Impact factor: 17.956

  3 in total
  3 in total

Review 1.  Getting Digital Assets from Public-Private Partnership Research Projects through "The Valley of Death," and Making Them Sustainable.

Authors:  Wendy Aartsen; Paul Peeters; Scott Wagers; Bryn Williams-Jones
Journal:  Front Med (Lausanne)       Date:  2018-03-09

2.  Benchmarking the scientific output of industrial wastewater research in Arab world by utilizing bibliometric techniques.

Authors:  Shaher H Zyoud; Aiman E Al-Rawajfeh; Hafez Q Shaheen; Daniela Fuchs-Hanusch
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-21       Impact factor: 4.223

3.  Control of Infectious Diseases in the Era of European Clinical Microbiology Laboratory Consolidation: New Challenges and Opportunities for the Patient and for Public Health Surveillance.

Authors:  Olivier Vandenberg; Zisis Kozlakidis; Jacques Schrenzel; Marc Jean Struelens; Judith Breuer
Journal:  Front Med (Lausanne)       Date:  2018-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.